| Denise Eileen Brooks, MS | |
|
7601 Redwood Rd Bldg E, West Jordan, UT 84084-4007 | |
| (801) 233-8670 | |
| Not Available |
| Full Name | Denise Eileen Brooks |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 12 Years |
| Location | 7601 Redwood Rd Bldg E, West Jordan, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164781852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mindful Mental Health Of Utah Llc | 1759765720 | 2 |
| Valley Mental Health Incorporated | 0042121196 | 64 |
News Archive
Researchers at The University of Texas Health Science Center at Houston are part of a multi-center, international study investigating the safety and best dosage of a clot-buster for children with acute ischemic stroke.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.
The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.
A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile model, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
› Verified 6 days ago
| Entity Name | Valley Mental Health Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275599797 PECOS PAC ID: 0042121196 Enrollment ID: O20031111000937 |
News Archive
Researchers at The University of Texas Health Science Center at Houston are part of a multi-center, international study investigating the safety and best dosage of a clot-buster for children with acute ischemic stroke.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.
The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.
A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile model, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
› Verified 6 days ago
| Entity Name | Mindful Mental Health Of Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922734391 PECOS PAC ID: 1759765720 Enrollment ID: O20220825002162 |
News Archive
Researchers at The University of Texas Health Science Center at Houston are part of a multi-center, international study investigating the safety and best dosage of a clot-buster for children with acute ischemic stroke.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.
The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.
A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile model, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Denise Eileen Brooks, MS 7265 S 1950 E #26, Slc, UT 84121-4875 Ph: (801) 750-4108 | Denise Eileen Brooks, MS 7601 Redwood Rd Bldg E, West Jordan, UT 84084-4007 Ph: (801) 233-8670 |
News Archive
Researchers at The University of Texas Health Science Center at Houston are part of a multi-center, international study investigating the safety and best dosage of a clot-buster for children with acute ischemic stroke.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.
The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.
A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile model, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
› Verified 6 days ago
Susannah Holden, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4983 W Amethyst Dr, West Jordan, UT 84081 Phone: 801-660-7194 | |
Mr. Spencer Giles Morgan, MSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9253 B Redwood Rd, West Jordan, UT 84088 Phone: 801-566-4079 | |
Chelsey Tautkus, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7601 South Redwood Road,, Building E, West Jordan, UT 84084 Phone: 801-233-8670 Fax: 801-233-8682 | |
Jessie Ann Ritchey, APRN Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7181 S Campus View Dr Ste 1a, West Jordan, UT 84084 Phone: 801-613-9843 | |
Janaka Vander Kooi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9263 Redwood Rd Bldg 8, West Jordan, UT 84088 Phone: 801-566-0749 Fax: 801-566-7108 | |
David Burrows, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8783 S Redwood Rd Ste C, West Jordan, UT 84088 Phone: 435-799-5035 Fax: 435-535-3782 | |
Carolyn Memmott, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8537 S Redwood Rd Ste C2, West Jordan, UT 84088 Phone: 801-829-9726 |